Author:
Giovannoni Gavin,Butzkueven Helmut,Dhib-Jalbut Suhayl,Hobart Jeremy,Kobelt Gisela,Pepper George,Sormani Maria Pia,Thalheim Christoph,Traboulsee Anthony,Vollmer Timothy
Subject
Neurology (clinical),Neurology,General Medicine
Reference338 articles.
1. A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis;Acaster;BMC Health Serv. Res.,2013
2. Delay in the diagnosis of multiple sclerosis in Croatia;Adamec;Clin. Neurol. Neurosurg.,2013
3. Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the TRANSFORMS and FREEDOMS studies by time since first symptom;Agius;CNS Neurosci. Ther.,2014
4. American Academy of Neurology, 2015. Availability of Disease Modifying Therapies (DMT) for Treatment of Relapsing Forms of Multiple Sclerosis. American Academy of Neurology. 〈https://www.aan.com/uploadedFiles/Website_Library_Assets/Documents/6.Public_Policy/1.Stay_Informed/2.Position_Statements/DiseaseModTheraMS_PosStatement.pdf〉 (accessed 04.06.15.).
5. Economic costs of diabetes in the U.S. in 2012;American Diabetes Association;Diabetes Care,2013
Cited by
272 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献